$3.33
-0.05-1.48%
At close: Jun 12, 5:00 PM EST
$3.57
0.247.21%
After Hours: Jun 12, 6:15 PM EST
SAB Biotherapeutics Inc Earnings Estimates
SABSNASDAQ
SAB Biotherapeutics Earnings Estimates, EPS & Revenue | NASDAQ:SABS
SAB Biotherapeutics (SABS) is scheduled to report Q2 earnings on August 6, 2026. Analysts estimate EPS of $-0.24 and quarterly revenue of N/A.
In the most recent quarter (Q1), SAB Biotherapeutics reported EPS of $-0.35, missing estimates of $-0.21 by 0.67%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
SAB Biotherapeutics has missed EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, SAB Biotherapeutics has averaged an EPS surprise of 0.49% and a revenue surprise of 1.00%.
Earnings Date
Aug 6
EPS Estimate
$-0.240
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
SAB Biotherapeutics Earnings History
Analyze the earnings history of SAB Biotherapeutics using advanced sorting and filters.
Loading calendar...
SAB Biotherapeutics (SABS) Earnings Per Share
The chart below shows SAB Biotherapeutics's reported EPS compared to analyst estimates over recent quarters.
SAB Biotherapeutics (SABS) Revenue
The chart below shows SAB Biotherapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is SAB Biotherapeutics (NASDAQ:SABS) reporting earnings?
SAB Biotherapeutics (SABS) is scheduled to report earnings on August 6, 2026. The last reported earnings were for reported on May 12, 2026 for Q1.
What were the latest earnings per share (EPS) for SAB Biotherapeutics (NASDAQ:SABS)?
The Actual EPS was $-0.35, which missed the estimate of $-0.21.
What were SAB Biotherapeutics’s (NASDAQ:SABS) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
